Halozyme Therapeutics Inc banner

Halozyme Therapeutics Inc
NASDAQ:HALO

Watchlist Manager
Halozyme Therapeutics Inc Logo
Halozyme Therapeutics Inc
NASDAQ:HALO
Watchlist
Price: 111.11 USD 1.16% Market Closed
Market Cap: $13.2B

Dividends

Halozyme Therapeutics Inc
does not pay dividends

Shareholder Yield

Current shareholder yield for HALO is hidden .

Shareholder Yield
LOCKED
Unlock
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Price Appreciation

HALO Price
Halozyme Therapeutics Inc

Annual Price Range
111.11
52w Low
61.63
52w High
115.22
Price Metrics
Average Annual Return 28.34%
Standard Deviation of Annual Returns 37.74%
Max Drawdown -49%
Shares Statistics
Market Capitalization 12.5B USD
Shares Outstanding 118 610 000
Percentage of Shares Shorted 14.42%

HALO Return Decomposition
Main factors of price return

Stock Splits

HALO's latest stock split occurred on Dec 10, 2003

The company executed a 171-for-40 stock split, meaning that for every 40 shares held, investors received 171 new shares.

The adjusted shares began trading on Dec 10, 2003. This was the only stock split in HALO's history.

Pre-Split Price
N/A
Post-Split Price
4.15
Before
After